Hemisphrex Announces Publication of Ampligen Safety Profile Across Diverse Animal Species
April 08, 2014 at 08:35 AM EDT
Hemispherx Biopharma, Inc. (NYSE: HEB) (the "Company" or "Hemispherx") announced today the peer-reviewed publication titled ...